CAMBRIDGE, Mass., Jan. 5 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. announced today that Jean-Pierre Sommadossi, Ph.D., Idenix’s chairman and chief executive officer, will present a corporate overview at the upcoming 24th Annual JPMorgan Healthcare Conference on Wednesday, January 11, 2006 at 2:00 p.m. at the Westin St. Francis, San Francisco.
The live and archived webcast of the presentation can be accessed under “Calendar of Events” in the Idenix Investor Center at http://www.idenix.com. The archived replays will be available on the Idenix website for two weeks following the presentations.
About Idenix
Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix’s current focus is on the treatment of infections caused by hepatitis B virus, hepatitis C virus and human immunodeficiency virus (HIV). Idenix’s headquarters are located in Cambridge, Massachusetts and it has drug discovery operations in Montpellier, France and Cagliari, Italy.
Contact:
Idenix Pharmaceuticals, Inc.
Teri Dahlman (617) 995-9905
Idenix Pharmaceuticals, Inc.
CONTACT: Teri Dahlman of Idenix Pharmaceuticals, Inc., +1-617-995-9905
Web site: http://www.idenix.com//
